Latest news:

Follicum AB attends and sponsors a conference in Basel

Follicum AB (“Follicum” or “the company”) announced today that the company will attend a conference in Basel ( and will also sponsor the conference with a small amount of money. Since the German research group who generated important parts of Follicum’s research data on human skin and human hair follicles will attend the conference, this […]

Sign up for our Newsletter


Our drug candidates both inhibit and stimulate hair growth, and as they are based on endogenous proteins they are considered safe

Read more


The global market is over 15 billion USD a year and increasing, with few competitors to our drug candidates

Read more


We want to develop safe, effective and cost effective drugs, suitable for both men and women, that have minimal side effects

Read more




06 Nov 17

Follicum will participate in the BioEurope Conference in Berlin, Germany, on 6-8 November 2017. More...